Metachromatic Leukodystrophy

Metachromatic Leukodystrophy

Visit and Join the WeHeal Metachromatic Leukodystrophy Community

Information and References: MayoClinic | Wikipedia | Healthline.com

Patient Resources and Related Organizations: MLD Foundation

News and Media: News-Medical.net | NIH

Clinical Trials: Clinicaltrials.gov | In Clinical Trials | EU Clinical Trials Register | | WeHeal Guide to Researching Clinical Trials

Search Clinical Trials

Metachromatic leukodystrophy (MLD) is part of a larger group of lysosomal storage diseases, some of which are progressive, inherited, and neurodegenerative disorders (metachromatic leukodystrophy included). Four types of metachromatic leukodystrophy occur with varying ages of onset and courses (ie, late infantile, early juvenile, late juvenile, adult). All forms of the disease involve a progressive deterioration of motor and neurocognitive function.

Visit and Join the WeHeal Metachromatic Leukodystrophy Community

WeHeal is very grateful to our valued sources of information which include Wikipedia, WebMD, ClinicalTrials.gov, Cancer.gov, Infoplease, and the US CDC (Center for Disease Control).